TY  - JOUR
JF  - ACS Applied Materials and Interfaces
VL  - 13
Y1  - 2021///
A1  - Ali, M.K.
A1  - Moshikur, R.M.
A1  - Wakabayashi, R.
A1  - Moniruzzaman, M.
A1  - Goto, M.
UR  - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85105906191&doi=10.1021%2facsami.1c03111&partnerID=40&md5=efab35b942c2096a0f97c1bbd89ae10d
N1  - cited By 37
AV  - none
SP  - 19745
PB  - American Chemical Society
IS  - 17
TI  - Biocompatible Ionic Liquid-Mediated Micelles for Enhanced Transdermal Delivery of Paclitaxel
KW  - Biocompatibility; Controlled drug delivery; Dynamic light scattering; High resolution transmission electron microscopy; Hydrogen bonds; Ionic liquids; Oleic acid; Targeted drug delivery
KW  -  Biocompatible surfactants; Cytotoxic agents; Drug delivery system; Franz diffusion cells; Physical stability; Skin irritation; Surface active ionic liquids; Transdermal delivery
KW  -  Micelles
KW  -  antineoplastic agent; biomaterial; ionic liquid; paclitaxel; surfactant
KW  -  animal; Bagg albino mouse; chemistry; cutaneous drug administration; drug delivery system; female; infrared spectroscopy; micelle; mouse; proton nuclear magnetic resonance; skin absorption
KW  -  Administration
KW  -  Cutaneous; Animals; Antineoplastic Agents
KW  -  Phytogenic; Biocompatible Materials; Drug Delivery Systems; Female; Ionic Liquids; Mice; Mice
KW  -  Inbred BALB C; Micelles; Paclitaxel; Proton Magnetic Resonance Spectroscopy; Skin Absorption; Spectroscopy
KW  -  Fourier Transform Infrared; Surface-Active Agents
SN  - 19448244
N2  - Chemotherapeutic cytotoxic agents such as paclitaxel (PTX) are considered essential for the treatment of various cancers. However, PTX injection is associated with severe systemic side effects and high rates of patient noncompliance. Micelle formulations (MFs) are nano-drug delivery systems that offer a solution to these problems. Herein, we report an advantageous carrier for the transdermal delivery of PTX comprising a new MF that consists of two biocompatible surfactants: cholinium oleate (ChoOle), which is a surface-active ionic liquid (SAIL), and sorbitan monolaurate (Span-20). A solubility assessment confirmed that PTX was readily solubilized in the SAIL-based micelles via multipoint hydrogen bonding and cation-Ï?and Ï?-Ï?interactions between PTX and SAILChoOle. Dynamic light scattering (DLS) and transmission electron microscopy revealed that in the presence of PTX, the MF formed spherical PTX-loaded micelles that were well-distributed in the range 8.7-25.3 nm. According to DLS, the sizes and size distributions of the micelle droplets did not change significantly over the entire storage period, attesting to their physical stability. In vitro transdermal assessments using a Franz diffusion cell revealed that the MF absorbed PTX 4 times more effectively than a Tween 80-based formulation and 6 times more effectively than an ethanol-based formulation. In vitro and in vivo skin irritation tests revealed that the new carrier had a negligible toxicity profile compared with a conventional ionic liquid-based carrier. Based on these findings, we believe that the SAILChoOle-based MF has potential as a biocompatible nanocarrier for the effective transdermal delivery of poorly soluble chemotherapeutics such as PTX. ©
EP  - 19755
ID  - scholars14942
ER  -